Supra bioavailable low dose pharmaceutical composition for treating muscle spasm, comprises chlorzoxazone or its salt, and excipient
2023-08-01
专利权人ZENVISION PHARMA LLP (ZENV-Non-standard)
申请日期2023-08-01
专利号IN202321051516-A
成果简介NOVELTY - A supra bioavailable low dose pharmaceutical composition comprises chlorzoxazone or its salt, and excipient. USE - Supra bioavailable low dose pharmaceutical composition for treating muscle spasm. No biological data given. ADVANTAGE - The pharmaceutical composition ensures at least 5% dose reduction, improved bioavailability, reduced adverse effects, improved therapeutic efficacy, and improved patient compliance in the treatment of muscle spasm.
IPC 分类号A61K-031/423 ; A61K-047/04 ; A61K-047/32 ; A61K-009/20 ; A61P-029/00
国家印度
专业领域医药卫生
语种英语
成果类型专利
文献类型科技成果
条目标识符http://119.78.100.226:8889/handle/3KE4DYBR/21017
专题中国科学院新疆生态与地理研究所
作者单位
ZENVISION PHARMA LLP (ZENV-Non-standard)
推荐引用方式
GB/T 7714
SIVAKUMAR B V,DHANANJAY T,DHIRAJ N,et al. Supra bioavailable low dose pharmaceutical composition for treating muscle spasm, comprises chlorzoxazone or its salt, and excipient. IN202321051516-A[P]. 2023.
条目包含的文件
条目无相关文件。
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。